| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 94.360 | 32.231 | 47.909 | 17.041 | 39.775 | 38.634 | 105.952 | 696.864 | 589.857 | 603.432 |
| Total Income - EUR | 96.661 | 32.231 | 47.909 | 26.969 | 39.775 | 38.634 | 106.948 | 706.969 | 598.915 | 604.339 |
| Total Expenses - EUR | 58.654 | 34.668 | 38.903 | 40.588 | 43.232 | 37.393 | 87.194 | 470.250 | 466.313 | 557.998 |
| Gross Profit/Loss - EUR | 38.007 | -2.437 | 9.005 | -13.620 | -3.458 | 1.241 | 19.753 | 236.719 | 132.602 | 46.341 |
| Net Profit/Loss - EUR | 32.092 | -3.082 | 8.526 | -13.890 | -3.856 | 894 | 19.516 | 230.417 | 127.496 | 37.074 |
| Employees | 3 | 3 | 3 | 3 | 4 | 3 | 6 | 14 | 11 | 14 |
Check the financial reports for the company - Bio-By Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.308 | 7.888 | 19.246 | 6.295 | 4.025 | 2.252 | 28.762 | 134.589 | 153.201 | 189.401 |
| Current Assets | 28.843 | 17.526 | 17.975 | 14.605 | 13.071 | 12.516 | 31.946 | 181.660 | 278.045 | 453.039 |
| Inventories | 18.157 | 16.135 | 15.531 | 14.124 | 12.181 | 11.985 | 24.742 | 77.455 | 186.106 | 302.763 |
| Receivables | 569 | 262 | 1.026 | 234 | 237 | 233 | 6.035 | 12.085 | 16.573 | 40.356 |
| Cash | 10.117 | 1.129 | 1.418 | 248 | 652 | 297 | 1.169 | 92.121 | 75.366 | 109.920 |
| Shareholders Funds | 25.553 | 22.211 | 30.361 | 15.914 | 11.750 | 12.421 | 31.662 | 230.543 | 213.602 | 199.726 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 4.084 | 4.061 |
| Debts | 6.598 | 3.203 | 6.860 | 4.986 | 5.346 | 2.347 | 29.046 | 85.706 | 217.644 | 442.713 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5611 - 5611" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Bio-By Srl